Kingsview Wealth Management’s iShares Global Healthcare ETF IXJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$720K Buy
7,317
+760
+12% +$71.5K 0.01% 849
2026
Q1
$613K Buy
6,557
+2,684
+69% +$263K 0.01% 831
2025
Q4
$377K Sell
3,873
-368
-9% -$34.8K 0.01% 945
2025
Q3
$376K Sell
4,241
-605
-12% -$52.3K 0.01% 891
2025
Q2
$417K Buy
4,846
+1
+0% +$86 0.01% 834
2025
Q1
$442K Hold
4,845
0.01% 768
2024
Q4
$417K Sell
4,845
-1,002
-17% -$92.6K 0.01% 801
2024
Q3
$574K Buy
5,847
+1,985
+51% +$192K 0.01% 669
2024
Q2
$359K Sell
3,862
-902
-19% -$82.3K 0.01% 786
2024
Q1
$444K Buy
+4,764
New +$431K 0.01% 695
2022
Q1
Sell
-12,389
Closed -$1.12M 941
2021
Q4
$1.12M Buy
+12,389
New +$1.07M 0.05% 359

Other funds holding IXJ

Kingsview Wealth Management's IXJ Position: Q2 2026 in Review

Kingsview Wealth Management increased its iShares Global Healthcare ETF (IXJ) stake by 12% in Q2 2026, buying an estimated $71.5K and bringing the position to 7,317 shares worth $720K. The position accounts for 0.01% of the portfolio, ranked #849.

Kingsview Wealth Management first reported a position in IXJ in Q4 2021 and has held it in 11 quarters since. The position peaked at $1.12M in Q4 2021. 301 funds tracked by Wall St. Rank hold IXJ as of Q2 2026.

  • Kingsview Wealth Management held 7,317 shares of iShares Global Healthcare ETF worth $720K as of Q2 2026.
  • Kingsview Wealth Management bought 760 iShares Global Healthcare ETF shares in Q2 2026, an estimated $71.5K.
  • iShares Global Healthcare ETF made up 0.01% of Kingsview Wealth Management's portfolio in Q2 2026, its #849 holding.
  • Kingsview Wealth Management first reported a position in iShares Global Healthcare ETF in Q4 2021 and has held it in 11 quarters since.
  • Kingsview Wealth Management's iShares Global Healthcare ETF position peaked at $1.12M in Q4 2021.
  • 301 funds tracked by Wall St. Rank held iShares Global Healthcare ETF as of Q2 2026.

Based on Kingsview Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.